@FierceMedDev: Treasury's crackdown on inversion could scupper Medtronic-Covidien deal. More | Follow @FierceMedDev
@MichaelGFierce: Vaxxas' nanopatch garners WHO support in search of #polio vax application. Story via FierceDrugDelivery | Follow @MichaelGFierce
@VarunSaxena2: In case you're wondering, $MDT can cancel its deal with $COV without penalty if it's due to changes in the tax code. Wonder what will happen. | Follow @VarunSaxena2
@EmilyWFierce: T2 Biosystems wins FDA approval for sepsis diagnostic system. More | Follow @EmilyWFierce
> Healthcare logistics company Owens & Minor acquired Ireland-based surgical kitting company ArcRoyal for an undisclosed amount in an effort to expand its global reach. Release
> Inivita, a clinical cancer genomics company, raised £4 million ($6.56 million) in a funding round led by Imperial Innovations. Release
> A major German insurance company is the first to reimburse for the ReWalk System, a robotic exosuit for spinal cord injury patients that FDA approved recently. Release
> Indian regulators are seriously considering instituting a price cap on medical devices in response to countrywide complaints of price gauging and bribery in the medical device industry. News
Biotech News
@FierceBiotech: If you missed yesterday's live #Fierce15 announcement, catch the replay from @partnering360. Watch | Follow @FierceBiotech
@JohnCFierce: Fun watching the inversion news bend from "Oh no!" to "Hey, wait a minute" this morning. Maybe not the kiss of death after all? | Follow @JohnCFierce
@DamianFierce: Fierce15 winner Molecular Partners just filed to raise ~$134M in a Swiss IPO. | Follow @DamianFierce
> Fast-tracked Ebola studies put Tekmira, Mapp and Sarepta in the spotlight. News
> Biogen shoulders into gene therapy amid a second honeymoon for the field. More
> NEA pitches in on a $27M gamble on Tracon's mid-stage cancer drug program. Story
> Who loses in biopharma as Treasury moves to block tax inversions? Article
Pharma News
@FiercePharma: Allergan rebuffed Actavis bid, saying it's 'closing in' on a $10B-plus Salix buy. Story | Follow @FiercePharma
@EricPFierce: Mylan proposes plan to avoid nitroglycerin shortage in Canada. Article via FiercePharmaManufacturing | Follow @EricPFierce
> Faltering Boehringer slashes 600 jobs in Germany in bid to save $580M. Story
> Heads will roll at GlaxoSmithKline, investors say. The question is, whose? Article
> Tax-deal crackdown's victims, say analysts? Mylan and Abbott, not Pfizer and AZ. News
Biotech Research News
> Researchers develop tumor-on-a-chip to test new cancer drugs. Article
> Genetic 'switch' may control aging process. News
> Drug development for tropical diseases gets $15.3M boost. Item
> Pathway discovery reveals another potential Alzheimer's drug target. Article
> New technique generates stem cells at highly efficient rate. Story
Pharma Manufacturing News
> GSK accidentally dumps 'liquid contaminated with poliovirus' into Belgian sewer system. Report
> Ritedose to invest up to $110M in South Carolina plant. Article
> Recall of Mylan nitroglycerin revised to avoid shortage. Story
> GSK influenza plant in Texas on track to start up in 2016. Item
> Merck KGaA deal for Sigma-Aldrich gets it some specialty manufacturing capacity. More